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Abstract 
Background: Most studies on the use of medicinal plants reported from Africa (including Ethiopia) have focused on 
the clinical actions of medicinal plants with little attention given to patient experiences in using these plants and 
factors impacting patients’ decisions about using them. 
Objectives: The main objective of this study is to explore the experiences of patients with diabetes attending treatment 
in the biomedical setting regarding their use of medicinal plants.  
Methods: Qualitative interviews were held with 39 purposively selected participants attending their treatment in 3 
public hospitals in urban centers of central Ethiopia. Interviews continued until key themes were saturated.     
Results: Medicinal plants were used alongside prescribed medicines with a range of factors impacting study 
participants decisions to trying out and continuing to use medicinal plants and also in recommending against their use 
or discontinuing them. Some of the main factors that encouraged use of medicinal plants include perceptions that bitter 
things were thought to be good for diabetes, their claimed and experienced benefits as well as the influence of others 
and the media while those that discouraged the use of medicinal plants primarily include safety concerns in relation to 
using the plants. 
Conclusions: The findings highlight the use of medicinal plants by patients with diabetes in the context of limited 
information. This is suggestive of the need for the healthcare practitioners in the conventional healthcare system to 
give more attention to patients’ interest in medicinal plants and for providing more evidence-based information about 
the plants used by these patients so as to improve health outcomes.  [Ethiop. J. Health Dev.  2017;31(1):18-26] 
Key words: medicinal plants, type 2 diabetes, Ethiopia, qualitative research 
 
Introduction 
Self-care practice using medicinal plants comprises one 
of the common forms of traditional medicine practices in 
Ethiopia. Limited quantitative surveys report that these 
practices are primarily used to treat acute conditions (1–
3), although there are a few reports of its use in chronic 
conditions such as diabetes (4,5). It was also apparent 
from studies done elsewhere and in Ethiopia that sizeable 
proportions of patients with diabetes used medicinal 
plants alongside the biomedicines although there was 
little or no interaction in this regard with their healthcare 
providers. Few studies from Africa including Ethiopia 
have cited different reasons that patients reportedly gave 
for using medicinal plants. These include them being a 
traditional option, efficacy in managing their condition, 
less expensive, ease of access, less restriction in terms of 
diet as compared to biomedicines among other things (5–
8). Furthermore, study participants had reported as to 
how they obtained information regarding these traditional 
medicines from lay individuals, mostly other patients, 
and that they had paucity of information about the 
recommended dosing (5,6,9). Some of the study 
participants had reported benefits from these medicinal 
plants including decrease in glycemic levels and 
resolution of diabetes-related symptoms but also 
experienced adverse effects including gastric disorders 
and hypoglycemic incidents (5,6). 
Most of the studies reported from Africa, including the 
one from Ethiopia, focused on the clinical aspects of 
specific medicinal plants used, but little attention was 
given to the patient perceptions with regard to their 
experiences in using (or not using) these medicinal 
plants. With this in mind, this qualitative study aims to 
explore in an in-depth manner the experiences with 
medicinal plants of patients with diabetes who are 
attending treatment in the biomedical setting. This study 
intended to explore the perceptions of not only those 
participants who have used medicinal plants but also 
those who have not further aim to explore possible 
reasons for not using them. 
 
Methods  
A qualitative method was selected in order to focus on 
the views and experiences of the study participants(10).  
This study was approved by the Institutional Review 
Board of the College of Health Sciences, Addis Ababa 
University (protocol number 036/13/PSP). All the 
hospitals have been where the study took place and gave 
consent for the study which was part of a PhD thesis. All 
study participants have given their written consent for 
this study. Anonymity was maintained by storing all data 
and presenting findings in a way that they cannot be 
traced back to individuals. 
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Study settings:  Sites for this study were three public 
hospitals in central Ethiopia. Two, namely Tikur Anbessa 
Specialized Hospital and Yekatit 12 Hospital, are located 
in Addis Ababa (the political and commercial capital of 
Ethiopia).  The third site, Butajira Hospital, which is the 
only public hospital in Butajira town, was included to 
explore the perceptions of patients living in the peri-
urban part of the country. A brief description of Addis 
Ababa and Butajira is given in Table 1. 
 
 
Table 1:  Description of study settings 
 Addis Ababa Butajira 
Significance  Largest urban center in the country  Home to AAU’s demographic 
surveillance site  
Population(26) 3.2 million  63,000,000  
Ethnic groups(27) Amhara (47%), Guragie (16.3%), 
Oromo (19.5%) and Tigrie (6.2%) 
Guragie (82%) 
Religions (27) Orthodox Christianity (74.7%),  
Islam (16.2%) and Protestant 
Christianity (7.8%) 
Islam (51.3%), Orthodox Christianity 
(39.6%) and Protestant Christianity 
(8.7%) 
Literacy (27) 85.3% 37.9% 
 
 
Tikur Anbessa Hospital is the largest teaching and 
national referral hospital in Ethiopia which manages 
patients with diabetes in its Diabetes Center. This clinical 
center was managed by three endocrinologists and two 
internists attending the endocrinology subspecialty 
program who worked as consultants on a rotation basis 
during the study period, five to six Internal Medicine 
residents assigned to take the primary role in managing 
the patients during their month long attachments, six 
nurses and one recently recruited pharmacist. Yekatit 12 
Hospital is a general hospital managed by the Addis 
Ababa City Administration which has recently become a 
training center for general practitioners (GP). Clinical 
services for patients with diabetes were primarily offered 
in the general outpatient department run during the study 
period by four general practitioners. Patients that were 
deemed to be in need of specialty care were referred to a 
medical clinic run by specialists who served on a rotation 
basis. Butajira is also a general hospital that has recently 
started serving patients with diabetes at a medical clinic 
along with other chronic conditions in the outpatient 
setting. This clinic was at the time run by a general 
practitioner and a nurse. 
 
Study participants recruitment:  Study participants were 
purposively selected patients with type 2 diabetes who 
were attending treatment during the study period in the 
selected hospitals. Criteria for inclusion in the study 
were: age 18 years and above, taking anti-diabetic 
medications for a minimum of one year and exhibiting no 
overt or known psychiatric problems. The sole exclusion 
criterion was being a healthcare provider. In addition, 
efforts were made to include patients with diverse socio-
demographic and economic characteristics (e.g. age, sex, 
marital status, religious affiliation, educational and 
income level, employment status, place of residence) and 
illness duration. The recruitment of study participants 
was facilitated by the nurses working in the respective 
clinics. These providers identified the patients and 
introduced the study. The first author followed this up by 
providing further information and recruiting eligible 
participants. 
 
Interview methods:  In-depth individual interviews with 
a median duration of 49 min (range from 30 to 120 min) 
were conducted starting from December 2013 until 
March 2014 by the first author. Interviews (completed in 
Amharic) were audio-recorded with the consent of 
participants. The interviews focused on the experiences 
that patients had with traditional medicinal plants 
including the types that they used, information sources 
about them, their reasons for trying out and using them, 
about any benefits obtained from them as well as 
concerns that they may have or experienced while using 
them. The interview guide was originally prepared in 
English and was translated to Amharic and then back to 
English to check its consistency, before the Amharic 
version was used for the study. 
 
Data analysis:  The interview data were transcribed by 
an experienced research assistant. The quality of the 
transcripts was checked by the first author by listening to 
randomly selected recordings from each site while 
reading the respective transcripts. These transcripts were 
repeatedly read which helped in the development of 
initial ideas which was followed by open coding to 
identify key content areas which were further classified 
into separate sub-themes and main themes using thematic 
analysis approach, which has been shown to be a flexible 
tool that can provide rich and detailed account of the 
findings (11). Coding of data obtained from each study 
site continued until key themes were saturated and no 
further information was emerging(10). Initial stages of 
the analysis were done in Amharic that was followed by 
further interpretation carried out after translating key 
parts of the transcripts, i.e. those relevant to the emerging 
themes, to English.  The first and last author worked 
together in this regard to interpret the key findings until 
consensus was reached. The qualitative data analysis 
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A total of 45 patients who fulfilled the inclusion criteria 
were invited of whom 39 actually took part in this study 
with the rest having been excluded due to refusal citing 
personal reasons or problems in telephone 
communication. Among the participants, 12 each (a total 
of 24) were from Tikur Anbessa and Yekatit 12 hospitals 
with the remaining from Butajira. Table 2 presents a 
summary of the relevant participant characteristics. As 
there was apparent difference in experiences and 
perceptions between the groups from Addis Ababa and 




Table 2: Study participatns’ characteristics (n=39) 
Socio-demographic Characteristics Number 
Sex  
   Female 19 
   <ale 20 
Age (years)  
   30-39 2 
   40-49 8 
   50-59 14 
   60-69 10 
   >70 5 
Educational status  
   Low education status (illiterate or basic literacy) 16 
   Elementary complete 8 
   Secondary school complete 8 
   Post-secondary school education 7 
Diabetes duration (years)  
   1-5 10 
   6-10 14 
   11-15 7 
   16-20 4 




  Glibenclamide + metformin 22 
   Glimepiride + metformin 1 
   Glibenclamide 1 
   Insulin 14 
   Insulin plus metformin 1 
 
 
The findings revealed that a little less than half of the 
study participants claimed to have used or briefly tried 
out medicinal plants for their diabetes, with all using it on 
a self-care basis except for one participant who made a 
visit to a traditional healer against his will by his family.  
The study participants identified 15 different medicinal 
plants believed to have some use in managing their 
diabetes.  The most commonly used medicinal plants 
included Moringa spp.  (Shiferas/ Haleko) and Ajuga 
spp. Focuses on  use, stopped using or decided not to use 
medicinal plants for their diabetes ‘Mostly they advise to 
take bitter things’ 
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Table 3: Traditional medicines used in the management of diabetes by study participants 
Local name* Scientific name Preparation and use Indication  
Shiferaw/Haleko Moringa spp. Dried, powdered leaves brewed and drank as tea; drink as juice after the brew cools; eaten as 




Ajuga spp. Fresh leaves washed with water and juice obtained from expressed leaves drunk Diabetes, hypertension 
Kosso Hagenia 
spp. 
The alcohol distilled from the dried and ground fruits and drunk either alone or after mixing 
with others such as lemon, netchshinkurt or garlic (Allium spp. and feto (Lepidium spp.) 
Diabetes mellitus, 
hypertension  
Abish (spice) Trigonella spp. Unspecified seed preparation taken orally Bitter, diabetes 
mellitus 
Meqmeqo Rumex spp. Dried, powdered root part brewed and drunk as tea Hypertension  
Gibto Lupinus spp. Seeds roasted a bit and soaked to reduce bitterness and then eaten Bitter, hypertension 
Kerkedi Hibiscus spp. Dried, unspecified parts drunk as tea Diabetes mellitus  
Grawa Vernonia spp. Expressed liquid from leaves drunk  Diabetes mellitus 
Qerefa (spice) Cinnamon spp. Dried bark ground and brewed as tea and drunk Diabetes mellitus 
Mix of telba, 




Telba and beso ground together which are added to the flesh of papaya to which water is 
added, allowed to stay overnight and decant the supernatant and then orally taken 
Mitigate burning 
feeling 
Damakesse Ocimumspp.  Fresh leaves rubbed and applied to the gums Inflammation (mitch) 
Lemon Citrus spp. Fresh fruit applied to the gums Gum bleeding 
Qey sir Beta spp. Boiled with water and water drunk Diabetes mellitus 
Tchat Catha spp. Fresh leaves chewed Bitter  
*All the local names for the medicinal plants are the Amharic versions except for Haleko (Moringaspp) which is term commonly used in South Ethiopia especially in 
Derashe and GamoGofa(18). 
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Among the factors that influenced participants’ use of 
traditional medicines is the widely held belief that bitter 
things are good for diabetes which has led to the use of 
traditional medicines such as Damakese (Ocimum spp.), 
Anamuro (Ajuga spp.), Abish (Trigonella spp.), 
Meqmeqo (Rumex spp.), Gibto (Lupinus spp.), Tchat 
(Catha spp.) and coffee. Such belief led some 
participants to try out and continue to take different 
traditional medicines, including the stimulant Tchat 
(Catha spp.). Some study participants however expressed 
how the extreme bitterness was actually a reason to 
refrain from trying out some traditional medicines such 
as Anamuro and to discontinue others, namely Grawa 
and Shiferaw.   
Bitter is also good for diabetes too. Mostly they 
advise to take bitter things (Female, low education, 
8 years with diabetes).  
Anamuro is good (for diabetes). I fear it and don't 
take it because it is very bitter (Female, low 
education, 7 years with diabetes). 
 
Benefits of traditional medicines: A number of the study 
participants identified perceived benefits and 
expectations which induced them to try traditional 
medicines. The most commonly mentioned claimed 
benefits especially of Shiferaw include cure from 
diabetes, controlling diabetes using Shiferaw only, 
reduction of the doses of prescribed medications when 
used concurrently and expectation to act as ‘additional 
vanguard’ to the medications being taken. On the other 
hand, belief that there is no benefit from taking 
traditional medicines was cited as reason not to try them. 
Many people say that they have been cured after 
taking it (Shiferaw) (Female, low education, 2 
years with diabetes). 
 
They are telling me about a traditional medicine 
known as Shiferaw. I just heard from a man whose 
sugar level has reached 90 while taking it. He told 
me that his dose has decreased from one and a half 
tablet to one. He plans to discontinue it (Shiferaw) 
and try it out with the (bio) medicine only; if the 
sugar level increases, he plans to abandon the 
medicine and take only Shiferaw (Female, 
elementary complete, 2 years with diabetes). 
 
Now that I think about the reasons why I took these 
medicines was that they might act as additional 
vanguards against things which may come through 
food or other ways. I didn't expect total cure from 
diabetes but to lessen the impact from some of these 
things (Male, high school graduate, 22 years with 
diabetes). 
 
I don't take traditional medicine. I have never 
taken. I don’t believe that those who have taken 
obtained any benefit from it (Male, low education, 6 
years with diabetes). 
 
Beliefs that one had observed the benefits such as 
decrease in blood glucose levels, relieving burning 
feelings and wound healing have been reported as 
common reasons for continued use of traditional 
medicines. In contrast, some of those who tried 
traditional medicines such as Shiferaw discontinued them 
if they thought they did not get that much benefit. 
The one called Shiferaw seems to be a good leaf. In 
fact I went for my appointment after having drunk it 
(for some time) and my levels have gone down to 
142… I am sure that it is not the medicines only 
that reduced the (sugar) levels… I am sure the 
reduction was due to the leaf. I only started 
metformin later on (Female, diploma graduate, 9 
years with diabetes). 
 
There is a leaf known as Anamuro (Ajuga sp.) 
which is claimed to be medicine for diabetes. It 
highly reduces it. The fresh leaves are washed with 
water and then the juice expressed which is then 
drunk. This should be followed with 2 eggs or one 
cup of butter as antidote. I take it from time to time 
and it actually reduces it (Male, low education, 1½ 
years with diabetes). 
 
It (Shiferaw) didn't reduce the sugar but reduced 
the tiredness. There were differences when you took 
it and when you didn't. But in general I didn't get 
that much benefit from it (explaining why he didn’t 
persist with it) (Male, diploma holder, 8 years with 
diabetes). 
 
Safety concerns about traditional medicines:  A number 
of study participants were non-supportive of the use of 
traditional medicines, with many of them warning against 
its use. Common reasons for this include unpleasant 
experience with a traditional healer and traditional 
medicine given, concern about unspecified dose and 
quantity of traditional medicine, fear of traditional 
medicine, observation of people who have died after 
abandoning their prescribed medications, experience of 
death of a close family member due to traditional 
medicines given by a traditional healer and personal 
experience of adverse effect after taking traditional 
medicine. 
 
Safety concerns, whether potential or observed in others, 
have been reasons for some study participants who have 
contemplated using traditional medicines but have 
refrained from using them to date. Some of these 
concerns include the uncertainty as to how it would 
interact with the biomedicine they are taking, fear that it 
may affect the liver and the heart, cause adverse effects 
especially if used regularly.  
Now there is a leaf known as Shiferaw. For those 
who took the ground material, they claim that the 
sugar has gone down. But I have fear that it may 
affect the liver. Even though I wanted to take it I 
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was afraid. When you take it regularly, I feared that 
it may have side-effects... There are many people 
including in my neighborhood who use it and claim 
that it was good. I have bought it but have still not 
used it out of fear. (Male, high school graduate, 14 
years with diabetes) 
 
Some of the participants who reported to have started 
using traditional medicines have discontinued because of 
the experience of adverse effects which they attributed to 
Shiferaw such as increased heartbeat and blood pressure, 
burning feeling in the ‘kidney’, low blood pressure and 
blood glucose or out of concerns that the dosage is 
unknown. Others have also cited the fear it may 
exacerbate existing kidney and abdominal problems to 
discontinue Kossoareqe (a hard liquor made from 
Kosso), and as well as abdominal side effects as reasons 
to discontinue Grawa. Alternatively, the absence of 
‘problems’ with the traditional medicine was a reason for 
one participant to continue using Shiferaw despite having 
not yet perceived any benefit from it. 
But do you test them? The one called Shiferaw 
seems to be a good leaf. In fact I went for my 
appointment after having drunk it (for some time) 
and my levels have gone down to 142 but there 
seems to be a problem with my heart beat. Perhaps 
I drank too many glasses… The blood pressure 
however highly increased [to reach180/120] and 
the doctor whom I saw that day tried to calm me 
and asked me to call family, which I did. He then 
examined me and ordered medicines. After a while 
and I have calmed down, he allowed me to go 
home. It worsened because I drank a lot from the 
leaves (as tea), which is my guess. After that I 
discontinued it. That time was very serious 
(Female, diploma graduate, 9 years with diabetes). 
 
I have used Moringa. It had indeed lowered it (my 
sugar levels) when I drank it as tea every morning 
after brewing it as a tea. After a week I felt light 
headed. When I went for tests to Arsho 
(Laboratories), they told me that the hemoglobin 
had reached 8. I took this result to Zewditu 
(Hospital). They asked me as to how it could 
happen while I was on Vitamin B12. I told them 
that I was taking Shiferaw. They told me to stop it 
or to take it once every 15 days. I was okay for the 
next 15 days. I stopped it thereafter. Previously my 
levels wouldn't go lower than 200 but while taking 
it (Moringa) it reached 105, 107 (Female, high 
school graduate, 6 years with diabetes). 
 
I don't agree with such kinds of things (referring to 
traditional herbal medicines). I am afraid of 
traditional medicines when a doctor is available. 
There are some for whom it does not agree with. 
For example, that individual may not know about it 
but the traditional medicine might damage his liver. 
If I tell you my experience, my sister was sick and 
she went to that traditional healer and the medicine 
affected her liver and she passed away. Her belly 
swelled and when she went to the hospital they 
asked what it was she drank but she died soon after. 
So I don't like it, I am afraid (Female, low 
education status, 3 years with diabetes). 
 
Influence of the media and significant others: 
Information obtained from the media such as broadcast 
media and the internet was among the reasons cited to 
influence taking medicinal plants. On the other hand, 
those who have contemplated using medicinal plants but 
refrained from using often cited safety concerns such as 
possible adverse effects. Moreover, those who have tried 
but were still concerned, articulated their desire to obtain 
credible and adequate information from their healthcare 
providers which unfortunately was not forthcoming. 
I even heard on TV (a satellite-based TV channel 
broadcasting in Amharic) doctors in the United 
States urging Ethiopian doctors to give (Moringa) 
to diabetic patients as it brings very good results 
(Female, high school graduate, 6 years with 
diabetes). 
 
Among factors that influenced study participants to try 
traditional medicines were recommendations from other 
patients or push from their families.  
I have been made to go to a traditional healer 
with push from my family. After payment of 
close to 600 birr (significant sum at the time of 
his visit), I was made to take ‘Altet’, a medicine 
for buda (evil eye) sold in Merkato, which had a 
very repulsive odor. For a whole month I was 
made to drink a bitter thing with coffee on empty 
stomach. It looks like mud, I don't even know 
what it is prepared from. Even after it was 
completed, there is the thing known as 
Armagusa. It is extremely bitter. It was brewed 
and placed in the fridge for me to take. I 
couldn't take it and then quarrelled with my 
family and left home (Male, high school 
graduate, 22 years with diabetes). 
 
Discussion 
This study has revealed the experience of participants 
with diabetes using medicinal plants that were taken 
alongside prescribed biomedicines. The major factors in 
the decisions patients made regarding the use of 
traditional medicines included: the perceptions that bitter 
things were good for diabetes; the claimed and perceived 
benefits of the medicinal plants; safety concerns; and the 
influence of others including the media. 
 
There seems to be a widely held belief among study 
participants that bitter things are good for diabetes and 
that one should take such things. This seems to be among 
the most common reasons for using medicinal plants 
including the psycho-stimulant Tchat (Catha spp.), 
whose fresh leaves were cited as beneficial for diabetes 
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although studies elsewhere have reported quite the 
reverse where chronic Tchat chewing led to increase in 
glucose levels in patients with diabetes (12). Perceptions 
that bitter things are thought to be good for the treatment 
of diabetes does not seem to be unique to Ethiopia. 
Studies involving participants of Indian and Bangladeshi 
origin have also reported traditional beliefs in the value 
of bitter foods and bitter herbs for the management of 
diabetes (13–15). While culture appears to influence 
these perceptions, recommendations by some healthcare 
providers to ‘take bitter things and avoid sweets’ seems 
to have a role in supporting these perceptions as observed 
in the present study. 
  
Claimed benefits, namely cure and controlling diabetes, 
solely using medicinal plants such as Shiferaw, were an 
important impetus for trying them. Hope for a cure is a 
belief held by many Ethiopians and is arguably much 
more attractive than taking medications for the rest of 
one’s life, which would induce them to try out different 
traditional and religious healing options including 
medicinal plants (16,17). Among the medicinal plants 
frequently mentioned were Shiferaw (Moringa spp.) and 
Anamuro (Ajuga spp.), which the study participants 
claimed to lower their blood glucose levels. Shiferaw 
(Moringa stenopetala) is a tree that is native to the 
southern part of Ethiopia where it is a staple food 
providing a good source of balanced diet. In addition to 
its use as food, the plant is also used for water treatment 
and as medicine for various conditions, including 
diabetes (18). Shiferaw was not mentioned as a medicinal 
plant by a study of herbal medicine use among Ethiopian 
patients with diabetes in 1985 (5), when this plant had 
not yet become a popular folk medicine in Ethiopia. 
Claims of anti-diabetic activities of these plants have 
previously been reported by other local studies (5,18) and 
there is some support from pharmacological studies of M. 
stenopetala carried out in animal models (19,20). M. 
oleifera was one of two most frequently mentioned 
medicinal plants identified by a study carried out among 
patients with diabetes in Senegal which also reported 
about its effectiveness to reduce blood glucose levels in 
diabetic rat models (6).  So it is possible that some of the 
traditional medicines may reduce diabetes symptoms; 
however, to date there is no evidence that they are as 
effective as or more effective than conventional 
pharmaceuticals or that they can ‘cure’ diabetes. 
 
Study participants also reported a number of concerns 
about traditional medicines in general and specifically 
about those commonly used for diabetes. The general 
safety concerns have to do with negative experiences that 
some of these study participants have encountered either 
personally or with a close family member or 
acquaintance.  The safety issues mostly had to do with 
lack of standardization about the doses and quantity of 
these medicines. Such concerns may emanate from the 
limited regulatory work in Ethiopia for traditional 
medicines despite the existence of a regulatory 
framework (21–23). Study participants, most of whom 
used these medicinal plants on a self-care basis reported 
experiencing a number of adverse effects including 
hypoglycemia, anemia and kidney, heart and abdominal 
problems. Such adverse outcomes are also reported 
elsewhere and it has been suggested that they may be 
related to patients’  inadequate knowledge about the 
doses, inherent toxicities of  these medicinal plants even 
at low doses as well as interactions with the biomedicines 
already taken for diabetes (6,9,24). 
 
This study may be limited by the fact that only patients 
with diabetes who were attending their treatment in the 
hospitals were included and that those who have avoided 
biomedicine and perhaps were more successfully 
managing their condition with medicinal plants upon the 
recommendation of a traditional healer or on self-
medication basis or were not included. The perspectives 
of traditional healers who routinely use and prescribe 
medicinal plants for the management of diabetes have not 
been included, which may be a further limitation. 
Nevertheless, great efforts have been made to include 
participants with diverse socio-demographic and 
economic backgrounds so as to be able to obtain a 
diverse outlook on the use of medicinal plants for the 
management of diabetes. 
 
Practice and research implications:  The findings of this 
study have different practice and research implications. 
With regards to practice implications, health providers 
need to regularly assess the use of medicinal plants with 
their patients, including their identity and mode of use. 
Based on the information obtained, they can make efforts 
to know further about those medicines so as to strive to 
provide evidence-based information. Patient education 
should be given about medicinal plants, including that 
they can have adverse effects and interaction with other 
medicines as is true with other biomedicines or existing 
illness. Patients’ perceptions related to ‘bitter diets’ need 
additional investigation and education should be 
provided that incorporates evidence-based information 
relevant to local contexts and cultures. Finally, sessions 
with patients should assess patient perceptions about 
diabetes including its incurability and provide need-based 
education in this regard. 
 
Evidence-based information about medicinal plants 
commonly used for the treatment of type2 diabetes could 
help providers and patients make more informed 
decisions. It is recommended that a survey is done to 
compile information about medicinal plants commonly 
used including the common local names of the medicinal 
plants, uses, expected adverse effects, potential 
interactions with biomedicines as well as with existing 
illness conditions. Such a study may also identify gaps 
for further pharmacological studies to assess about 
efficacy, adverse effects and interactions among other 
things. In relation, the perspectives of patients with 
diabetes who do not follow treatment in a biomedical 
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setting as well as those of traditional healers and 
herbalists need to be included in the survey. Such 
information can be used by providers in their counseling 
of the patients and for the media, as well as for patients 
provided it is availed in local languages. 
 
Government needs to work to implement the regulatory 
frameworks stipulated to improve the safety, efficacy and 
quality of at least the commonly used medicinal plants as 
it has also been recommended by the World Health 
Organization. This may involve instituting measures to 
ensure that any medicinal plant approved for sale to the 
community is safe, fulfills minimal information required 
for the appropriate use by patients and is of suitable 
quality. Furthermore, the pharmacovigilance program 
currently in place in the country should be designed and 
promoted to include adverse effects as a result of 
medicinal plants that may be taken by patients. The 
national medicine regulatory body should also strive to 
provide evidence-based information to consumers, 
healthcare providers and traditional healers and others 




The present study is indicative of the use of medicinal 
plants by patients with diabetes in the context of very 
limited information which can easily contribute to 
suboptimal health outcomes among these patients. This 
calls for more attention to the use of medicinal plants and 
for the provision of evidence-based information to these 
patients and their healthcare providers. 
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